they were sedatives); structuring more invasive treatment options, as these are associated with larger placebo effects; and making sure to explore "nocebogenic" effects (adverse side effects of placebos) of medications/procedures so that patients may be warned about them in order to help increase adherence. These are all felt to be useful elements of the doctor-patient relationship.
Moerman and Jonas 11 also examine the nature of the placebo concept and the need to differentiate it from factors such as regression to the mean, natural history of disease, and unconscious investigator bias. They propose a different term, which may apply to the types of studies mentioned above in which instructions or number of pills-the social context of placebo drug delivery-play a role in effect. This term, the "meaning response," refers to the "physiologic or psychological effects of meaning in the origins or treatment of illness." 11 Meaning responses elicited by the administration of sham treatments can be called placebo effects. Moerman and Jonas have thus usefully separated the dimensions of the social context of delivery of treatment from the statistical effects such as natural history of disease. In support of the importance of meaning responses, they explore the culturebound effects of meaning. In one example, the differences in death rates in Chinese Americans and whites are related to years considered lucky or unlucky by Chinese traditional astrology, as they relate to specific disease types. Chinese Americans who died of lymphatic cancers who were born in unlucky years died at an average age of 4 years younger than Chinese Americans who were not born in unlucky years; no such pattern was seen in whites. This 4-year difference represents nearly 7% of the entire life span and is apparently based largely on meaning.
Meaning, Moerman and Jonas 11 observe, has been taken out of medicine as it becomes progressively rationalized. They question whether we have lost something in the translation. Debate on placebo and meaning responses is currently ongoing, and our directions, beyond the recognition of the continuing validity of both randomized placebo-controlled trials and mind-body medicine, are still unclear. What are the meanings, for instance, of different placebos used in studies of complementary medicine, and do they affect our ability to study these techniques? Has the meaning of antidepressant treatment changed over the past 2 decades, giving rise to the trend of increasing placebo responses? Or do the time-linked differences in placebo response arise from changes in populations recruited for clinical studies during that time? As doctors and patients try to optimize integrative treatment, both technical and psychological questions about placebo responses need deeper examination. 
Charlotte Gyllenhaal, PhD

Colon Cancer and the Western Diet
Colorectal carcinoma (CRC) is the second largest cause of cancer-related mortality in the United States and is the focus of intensive research at clinical and academic centers throughout the world. Risk factors for CRC include family history of cancers of the colon, rectum, breast, or endometrium; inflammatory bowel disease (eg, irritable bowel syndrome); central adiposity; and physical inactivity. 1,2 CRC, when diagnosed at an early stage of disease, is a highly treatable cancer, with survival rates as high as 90%. Unfortunately, public awareness of the signs and symptoms of colorectal carcinoma has remained notoriously low, and this fact has led to a needlessly inflated rate of mortality; in 2002, an estimated 56,600 deaths due to CRC, of 148,300 new cases, will occur. 3 CRC usually develops first as benign polyps (growths) within the tissues of the colon or rectum. These developments are warning signals that often herald the eventual progression to cancer. At these and later stages, signs and symptoms often include mild abdominal discomfort, low levels of blood in stool, altered bowel habits, and symptoms mirroring peptic ulcer. A useful and sensitive test used to detect blood in the stool is the guaiaic test; a positive guaiaic test should be followed by further investigation. Polyps are often easily removed surgically.
Research over the years has contributed to the understanding of CRC. One of the most obvious epidemiological discoveries was a strongly positive correlation between colorectal cancer and typical Western dietary components; evidence was published that illustrated an increased CRC risk among populations with high intake of dietary fat and low intake of dietary fiber. Some researchers reasoned that secretion of bile acids caused by ingestion of dietary fat increased the level of bile acid breakdown products, some with alleged roles in proliferation and mutagenesis. [4] [5] [6] Dietary intake of fiber, on the other hand, was claimed to reduce overall risk of CRC by reducing the exposure of colonic cells to carcinogens and bile acids through binding, dilution, and reduction of transit times. 6 However, several more recent articles have cast doubt on the allegedly definitive role played by fat and fiber in the epidemiology of colorectal cancers. 7, 8 New evidence is accumulating that points a finger at other culprits, for example, chronically high levels of insulin and insulin-like growth factors (IGFs).
The mechanisms through which insulin and IGFs are thought to influence metabolic processes related to cancer have been recently summarized in a comprehensive review by Giovannucci. 9 In brief, high circulating levels of insulin (hyperinsulinemia) and insulinlike growth factors are associated with increased risk of colon and other cancers. 10 In a recent research article published in the journal Diabetes, Technology and Therapeutics, the authors note that "hyperinsulinemia may underlie the cancer associations of several . . . risk factors, including high waist circumference, visceral fat, waist-to-hip ratio, body mass index, sedentary lifestyle, and energy intake." 11(p263) Others have reported correlations between increases in dietary intake of simple sugars and starches (leading to high levels of insulin) and colonic cell proliferation. 12, 13 A variety of chemomechanistic explanations have been put forth as possible explanations for these observations, involving interactions with ras protein mutations, mitogenicity, stimulation of farnesyl transferase, apoptosis modulation, and stimulation of the production of vascular endothelial growth factor.
Epidemiologic, in vitro, and in vivo studies appear to support the idea that hyperinsulinemia and high levels of the IGF axis are important factors influencing carcinogenesis. 9 It is probable that the evidence implicating high intake of dietary fat and low intake of dietary fiber does represent an aspect of overall lifetime cancer risk, although the current data add another important facet to the physiology of these diseases. Complex though it may seem, dietary (regular intake of high levels of simple sugars, some starches, and other foods that stimulate insulin secretion) and lifestyle (exercise, weight management) choices leading to insulin resistance and chronic hyperinsulinemia are factors that must not be ignored when considering risk and management of colon cancer.
DNA Repair in Skin Cancer Prevention
Xeroderma pigmentosum, an autosomal recessive disease, includes among its effects an extremely elevated risk for malignancies in sun-exposed skin. This condition arises because of an altered enzyme involved in the repair of DNA damaged by ultraviolet (UV) light. However, it is not only people who suffer from this rare condition who may look forward to a future bout with skin cancer-the damage done to our genetic blue-print by exposure to ultraviolet radiation is a major risk factor for skin cancers in everyone. For some, including those with xeroderma pigmentosum and others at higher risk, a life indoors has been the only option. Afraid for their health, many otherwise healthy people have decided that the best way to avoid skin damage and elevated cancer risk is to stay out of the light.
In a preliminary study reported by Yarosh et al 1 in Lancet, the investigators report progress on the development of a topical preparation that may help elucidate a better option. The product was developed using a DNA repair enzyme called T4 endonuclease V (T4N5). T4N5 is an enzyme found in some bacteria that serves a similar function by repairing UV-induced DNA damage. The enzyme is not ingested or injected, but is rather encapsulated in liposomes that facilitate absorption into skin cells. Transmembrane delivery of the active ingredient enables the enzyme to do its work where it is needed, intracellularly. Topical use of the liposome suspension as a lotion showed an "accelerated . . . removal of ultraviolet-light-induced DNA damage (specifically cyclobutane pyrimidine dimers) compared with placebo." 1(p926) The treatment is apparently without side effects, is not systemically absorbed, and does not generate an antibody response. 1, 2 The lotion has so far been tested on 30 patients with xeroderma pigmentosum in a prospective doubleblind study. Incidences of basal cell carcinoma and actinic keratoses were reduced by 30% and 68%, respectively, compared with placebo. An expanded human trial is planned for test centers in California and Florida.
More Evidence for Green Tea's Unusual Chemoprevention Activity
Green tea, one of the world's most consumed sources of the stimulant alkaloids caffeine and theobromine, is made by infusing the leaves of the tea tree Camellia sinensis (L.) Kuntze [Theaceae]. Drinking green tea has long been considered beneficial to health, and research appears to support this ancient wisdom. Recently, the cancer chemopreventive properties of chemicals found in green tea have been the subject of much investigation. The focus has been on a very large group of polyphenolic compounds, called catechins, that have been seen to protect DNA under adverse conditions including oxidative stress. Characterization of the nature of this protective effect, and at what concentrations such protection is meaningful, has been a difficult question to answer.
In a recent article in Carcinogenesis, 1 4 catechins believed to be responsible for chemopreventive effects were tested under laboratory conditions. Different concentrations of the catechins (-)epicatechin, (-)-epigallocatechin, (-)-epicatechin gallate, and (-)-epigallocatechin gallate (EGCG) were included in an in vitro test that measures the level of free-radical damage done to DNA. The analyses included the measurement of the number of DNA strand breaks due to hydroxyl (•OH) radicals, generated under controlled conditions, and the prevention of such breaks when in the presence of the different catechins. Protection from breakage was concentration dependent, with the highest level of protection seen with EGCG at 100 µM.
This study suggests that the major cancer chemopreventive effect of catechins such as EGCG is due to their ability to reduce oxidative damage caused by hydroxyl radical attack. Unlike the previously suggested mechanism of action, the data reported in this article suggest that DNA protection is not due to the interception of •OH and other free radicals before they have a chance to damage DNA (called direct freeradical scavenging). Instead, it would appear that EGCG and, to a lesser extent, the other catechins tested act by repairing radical damage already done to DNA by a mechanism of electron and/or hydrogen atom transfer from the catechin to the free-radicaldamaged sites on DNA. The authors suggest that this reaction takes place so quickly that the damaged DNA is repaired in time to prevent further damage such as strand breakage. It is unclear whether this newly proposed mechanism of chemoprevention also applies to the activity of other bioactive flavonoids. 
Eat Your Garlic!
Garlic (Allium sativum L.) has been a favorite food and medicine for millennia. Many medical benefits have been claimed for this plant, including antibiotic, antihypercholesterolemic, and antithrombotic activities. These biological effects have been attributed to the strong-smelling compound allicin and the many malodorous sulfur compounds that it quickly breaks down to. Much research has focused on these biological activities of the various compounds of the alliums, resulting in thousands of publications from home health books to peer-reviewed research articles. Anticancer effects of garlic compounds have been less thoroughly investigated. Various laboratory investigations, including several using well-defined animal models using chemically induced malignancies, have shown chemopreventive and antiproliferative effects, 1,2 tumor size reduction, 3 apoptotic effects, 4 and antimitotic effects. 3 Resolving the question of how these effects are achieved has been difficult, however.
A report from France's Nutrition and Gastrointestinal Laboratories (Laboratoire de Nutrition et Securite Alimentaire, Institut National de la Recherche Agronomique, 78350 Jouy-en-Josas) published in Carcinogenesis 5 presents evidence in support of an antimitotic potential of some garlic compounds. Antimitotic effects have been previously described for garlic products in other human cells, 6 although the mechanisms of action have been more difficult to elucidate. The evidence presented in a report by Veronique et al 5 indicates that one of the many sulfurous breakdown products of allicin called diallyl disulfide (DADS) induced notable changes in colon carcinoma cell metabolism, cell cycle, and overall adhesion properties in subpopulations of the cell lines studied.
One of the possible effects of DADS had been thought to be an ability to reduce a cancer cell's ability to synthesize the compound glutathione. It has been reported that a cancer cell population's response to certain chemotherapies, especially the antimitotic drugs, is greater when those cells' ability to synthesize the compound glutathione is decreased. 7, 8 This would be an important effect, and would affect our ability to modulate our own cancer's susceptibility to certain standard chemotherapeutic drugs. The new research article reports that the de novo synthesis of glutathione in HT-29 colon carcinoma cells is unaffected by DADS; in this case, it would seem, any DADSrelated anticancer effect would not be linked to a reduction in synthesis of glutathione. Studies in other cell lines seem to be warranted.
DADS was seen to induce changes in certain other metabolic processes, however, including protein synthesis and polyamine metabolism. 5 Protein synthesis capacity was seen to decrease by greater than 75% in non-DADS-resistant cell populations, which has an effect on the rate at which cancer cells multiply. In addition, polyamine metabolism was shown to be strongly inhibited by treatment with DADS in non-DADS-resistant cell populations. Polyamine metabolism inhibitors have been previously described as having good potential for treatment and prevention of certain cancers due in part to the fact that these metabolites play a role in the cancer cell's ability to adhere to healthy tissues. 9 By diminishing the ability of colon cancer cells to multiply and to maintain their "grip" on healthy tissue, DADS may exert an overall chemopreventive effect. providers are changing; quality of life after diagnosis has become as important a question as length of life after diagnosis.
Winningham's article provides a review of the historical and phenomenal aspects of what is now known as cancer-related fatigue syndrome. New, multidimensional approaches to rehabilitation and intervention techniques are explained. These approaches are developed from several perspectives, from that of energy production and depletion at the cellular level to that of pharmacologic management options for specific symptom management. Aspects of oncology rehabilitation that are addressed include dietary therapy, cognitive issues, sleep therapy, and endurance exercise training. For patients and providers, this publication provides a valuable foundation for developing an appreciation for this particular aspect of cancer.
